T he American Heart Association recently defined as a goal, "By 2020, to improve the cardiovascular health of all Americans by 20% while reducing deaths from cardiovascular diseases and stroke by 20%." 1 These are bold objectives, which represent a substantial challenge to care providers, patients, stakeholders, and populations in view of alarming trends in obesity and diabetes. 2 To demonstrate success, we must be able to monitor progress. Our ability to do so is challenged by the lack of a national system to conduct surveillance of cardiovascular disease, which hinders our assessment of the effectiveness of interventions aiming at improving its outcome in populations. 3 Without a national system, the surveillance of cardiovascular disease relies on a multitier strategy leveraging vital statistics, administrative datasets, community surveillance programs, and local registries. In the present issue of Circulation: Cardiovascular Quality and Outcomes, an important article by Kostis et al 4 illustrates the use of such an approach for surveillance of cardiovascular disease by reporting on trends in the prognosis of patients with acute myocardial infarction hospitalized in New Jersey hospitals. Using the Myocardial Infarction Data Acquisition System (MIDAS), which contains hospital discharge data from nonfederal acute care hospitals in New Jersey, the authors examined the outcomes of 285 387 patients hospitalized with a first myocardial infarction between 1986 and 2007. The length of hospital stay decreased, as did in-hospital mortality. Importantly, 30-day mortality, a critical indicator, which is independent of length of hospital stay, was nearly cut in half, as it decreased markedly as well from 18% to 10%. Conversely, a small but definite increase in mortality beyond 30 days and up to 1 year after myocardial infarction was detected with an increase of 1.2% over the time period. This increase is small but is a signal that should not be ignored. It was particularly evident among older age groups and, importantly, was due to noncardiovascular causes, in particular, respiratory and renal disease, as well as septicemia and cancer. This increase in noncardiovascular mortality was independent of age, sex, complications of myocardial infarction, and interventions.
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The central message of the Kostis article 4 is that patients hospitalized with myocardial infarction in New Jersey are less likely to die within 30 days of their infarction in 2007 than 20 years ago. However, they are now more likely to die later and of illnesses such respiratory or kidney diseases or cancer. This is a substantial paradigm shift that only studies focusing on population trends are positioned to detect. In reacting to such a report, the validity of the data should always be discussed because MIDAS, like any study, will have its own share of methodological limitations (such as shift in coding practices, increased documentation requirements in the medical records, change in diagnostic assays, etc). However, the data in the Kostis report 4 are consistent with several studies published in the past year that all have documented a profound change in the epidemiology of myocardial infarction. [5] [6] [7] Indeed, these population studies have reported a decrease in the incidence of myocardial infarction and a shift in case mix characterized by a dramatic decline in the incidence of ST-segment elevation-myocardial infarction associated with an increase in the incidence of non-ST-segment elevation-myocardial infarction. Importantly, these changes, although they may have been amplified by the change in the definition of myocardial infarction, 8 predated the introduction of troponin as the biomarker of choice for the diagnosis of myocardial infarction. 5 With regard to outcomes, these reports documented a decline in short-term case-fatality rate and in cardiovascular mortality but no change in total mortality. This translates into a shift in the cause of death from cardiovascular to noncardiovascular among myocardial infarction survivors. The Kostis data 4 are consistent with these findings, and the coherence across studies attests to the robustness of the data and support their validity.
Implications
Let's pause to ask ourselves what these data really mean. To the emergency department physicians, the interventional cardiologists, and acute care providers, this is unambiguously a message of good news. The battle of the past 2 decades to improve the care of hospitalized myocardial infarction, initiated on the basis of robust evidence, is finally paying off. The impact of programs such as the American Heart Association Get With The Guidelines further underscores that improving care can be achieved. 9 Importantly, improvement is demonstrated not only by favorable changes in process measures but also by improvement in outcomes, as detected in registries such as CRUSADE (Can Rapid Risk Stratification of Unsta-ble Angina Patients Suppress Adverse Outcomes), 10 in the present report, and in population studies. 5, 6, 11 Although we may have won a battle, however, we have not won the war. Indeed, disparities in care persist and demand urgent and vigorous attention, thus precluding any inclination to complacency. 7 To this end, there are alarming data suggesting that the favorable trends in the outcomes of myocardial infarction may not have been experienced equally by all groups and that there are substantial disparities with deleterious outcomes persisting among blacks. 7 This further emphasizes the importance of a robust surveillance system, which can capture the trends over time according to race and ethnicity. Further, the care of myocardial infarction is heterogeneous as the disease itself is heterogeneous, and there is evidence from CRUSADE that the care of non-ST-segment elevation acute coronary syndromes still presents substantial opportunities for improvement. 10 To our patients with acute coronary syndromes, the Kostis report 4 is also wonderful news: Providing that care can be accessed, we as care providers can deliver effective treatments that reduce their risk of dying, at least short term. The "short-term" aspect is a critical component of this discussion and delineates a new challenge: recommitting to holistic care for our patients.
Need for a Holistic Approach to Care
Indeed, as the cause of death after myocardial infarction is shifting toward noncardiovascular causes, improving longterm outcomes requires expanding care strategies beyond the boundaries of the heart to target chronic diseases, the determinants of these adverse long-term outcomes.
One could argue that the imperative for patient-centric versus organ-centric care is hardly a novel concept. This is true, as indeed the guidelines of the American Heart Association/American College of Cardiology on acute coronary syndromes, published in 2007, underscore the need to assess general health, comorbidity, cognitive status, and life expectancy. 13, 14 However, implementing these recommendations is more complex. Indeed, addressing this need requires including in the care of elderly with acute coronary syndromes key constructs such as frailty, cognition, and physical function. All entities can profoundly affect the effective delivery of care and subsequent outcomes and should be included in the evaluation of patients with myocardial infarction. In addition, the role of patient-centered measures such as health status is increasingly recognized as a central determinant of care-seeking behaviors and outcomes. This is aligned with recommendations from the National Heart, Lung, and Blood Institute Working Group on Outcomes Research in Cardiovascular Disease. 15 Despite their conceptual importance, these constructs (frailty, cognition, physical function, and health status) are seldom, if ever, formally evaluated in clinical practice. The data by Kostis et al 4 underscore the urgent need to expand our scope of care from the heart to the patient to foster care effectiveness by focusing on global health and optimize the use of healthcare resources. How could we do this, in the face of increasing pressures to cut costs and shorten hospital stays? The acute treatment of myocardial infarction should remain geared primarily toward the timely treatment of coronary obstruction and the initial implementation of lifesaving, evidence-based cardiac care. Perhaps is it time to reengineer the role and scope of cardiac rehabilitation, which remains underused, to expand it toward the systematic appraisal of the burden of chronic diseases and its management. Although this is a hypothesis that would have to be tested, the data by Kostis et al and others [5] [6] [7] certainly challenge us to give it some thought. Effective partnership between cardiologists and primary care providers is equally vital for the delivery of holistic care, underscoring the pivotal importance of cohesive care transitions.
The Institute of Medicine defines quality of care as "the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge." 16 This statement implies that the quality of care must be contextualized to understand the outcomes observed and define strategies to improve them when necessary. The article by Kostis et al 4 points to a new direction for our efforts in this regard.
